(Q72662551)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7903785%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

review article

1 reference

title

Management of non-insulin-dependent diabetes mellitus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7903785%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

author name string

G Williams

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7903785%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

language of work or name

English

0 references

publication date

1 January 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7903785%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7903785%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

343

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7903785%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

8889

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7903785%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

95-100

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7903785%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990822-2

7 January 2021

Insulin use in NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990822-2

7 January 2021

Management of non-insulin-dependent diabetes mellitus in Europe: a concensus view

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990822-2

7 January 2021

Management of dyslipidemia in NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990822-2

7 January 2021

Sodium restriction and blood pressure in hypertensive type II diabetics: randomised blind controlled and crossover studies of moderate sodium restriction and sodium supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990822-2

7 January 2021

How can we best prolong life? Benefits of coronary risk factor reduction in non-diabetic and diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990822-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990822-2

1 reference

7 January 2021

Consensus Development Conference on Diet and Exercise in Non-Insulin-Dependent Diabetes Mellitus. National Institutes of Health

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990822-2

7 January 2021

Pathogenesis of non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990822-2

7 January 2021

Secondary failure to treatment with oral antidiabetic agents in non-insulin-dependent diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990822-2

7 January 2021

What is the benefit of increasing the sulfonylurea dose?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990822-2

7 January 2021

Biguanides and sulfonylureas as combination therapy in NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990822-2

7 January 2021

Intensive conventional insulin therapy for type II diabetes. Metabolic effects during a 6-mo outpatient trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990822-2

7 January 2021

Insulin and atheroma--an update

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990822-2

7 January 2021

In defence of insulin: a critique of syndrome X

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990822-2

7 January 2021

Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990822-2

7 January 2021

Comparison of morning or bedtime insulin with and without glyburide in secondary sulfonylurea failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990822-2

7 January 2021

Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A metaanalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990822-2

7 January 2021

Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990822-2

7 January 2021

Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990822-2

7 January 2021

Five-year follow-up study on plasma insulin levels in newly diagnosed NIDDM patients and nondiabetic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990822-2

7 January 2021

Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990822-2

7 January 2021

Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990822-2

7 January 2021

10.1016/S0140-6736(94)90822-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7903785%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference